By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IMPAX Laboratories 

30831 Huntwood Avenue

Hayward  California  94544  U.S.A.
Phone: 510-476-2000 Fax: 510-471-3200



Drug Delivery

Company News
IMPAX Labs (IPXL) To Report First Quarter 2015 Results On May 11, 2015 4/16/2015 7:50:36 AM
IMPAX Labs (IPXL) Completes Acquisition Of Tower Holdings, Inc. And Lineage Therapeutics Inc. 3/10/2015 7:19:58 AM
IMPAX Labs (IPXL) To Present At The Cowen and Company 35th Annual Health Care Conference 2/25/2015 9:52:07 AM
IMPAX Labs (IPXL) Revenues Increased 30% To $131 Million In Fourth Quarter 2014 2/24/2015 8:17:08 AM
Alaska AG Investigating Bay Area's IMPAX Labs (IPXL) Over Possible Pay-to-Delay Deals 2/13/2015 6:09:35 AM
IMPAX Laboratories, Inc. (IPXL) To Report Fourth Quarter 2014 Results On February 24, 2015 1/29/2015 8:21:14 AM
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For A Generic Version Of Lamictal® Orally Disintegrating Tablets (ODT) 1/26/2015 7:30:28 AM
IMPAX Laboratories, Inc. (IPXL) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/6/2015 11:00:32 AM
IMPAX Laboratories, Inc. (IPXL) To Present At The 2014 Credit Suisse Healthcare Conference On November 11 11/10/2014 9:28:29 AM
IMPAX Laboratories, Inc. (IPXL) Submits Marketing Authorization Application To EMA For IPX066 (Carbidopa-Levodopa) Extended-Release Capsules 11/6/2014 8:17:15 AM